2m 2m 2m 2m 2m 2m 2m
ADMA Biologics (ADMA)
NASDAQ
$13.34+$0.15 (+1.10%)
Price as of Nov 12, 2026 10:02 AM EST- $2.9BMarket Cap
- -19.87%1-Year Change
- BiotechnologyIndustry
ADMA Biologics (ADMA)
$13.34+$0.15 (+1.10%)
Earnings Score
Valuation | ADMA | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | 0 | ||
Low Earnings Volatility | 4 |
Momentum Score
Valuation | ADMA | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 4.09% | ||
12-Month Momentum | -35.68% | ||
3-Month Risk Adjusted Momentum | 24.69% | ||
12-Month Risk Adjusted Momentum | -69.47% |
True Yield
Valuation | ADMA | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 8.03% | ||
Net Debt Paydown Yield | 0.02% |
Financial Health Score
Valuation | ADMA | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 9 |